Carlos F Silva Dpm Pc Podiatrist - Primary Podiatric Medicine Medicare: Medicare Enrolled Practice Location: 8375 Woodhaven Blvd Ste Lb4, Woodhaven, NY 11421 Phone: 718-805-3338 Fax: 718-441-4872 |
Dr. Carlos Fredy Silva, DPM Podiatrist - Primary Podiatric Medicine Medicare: May Accept Medicare Assignments Practice Location: 83-75 Woodhaven Blvd, # Lb4, Woodhaven, NY 11421 Phone: 718-805-3338 Fax: 718-441-4872 |
Dr. Allan Friedman, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 87-05 Jamaica Ave, Woodhaven, NY 11421 Phone: 718-441-6550 Fax: 718-441-6993 |
Dr. Jimmy Li, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 8612 Jamaica Ave, Woodhaven, NY 11421 Phone: 718-846-7872 Fax: 718-846-6001 |
Dr. Robert J. Castelli Dpm Pc Podiatrist - Foot Surgery Medicare: Medicare Enrolled Practice Location: 8612 Jamaica Ave, Woodhaven, NY 11421 Phone: 718-846-7872 Fax: 718-846-6001 |
News Archive
Updated Phase 1/2a results with GEN-003, a vaccine candidate under development by Genocea Biosciences, Inc. (Nasdaq: GNCA) for the treatment of herpes simplex virus type 2 (HSV-2) infection, showed the experimental vaccine to generate highly significant reductions in both the number of clinical lesion days and rate of viral shedding at six months after the final vaccine dose.
Chai-Na-Ta Corp., one of the world's largest suppliers of North American ginseng, today announced a third quarter 2009 net loss of $136,000, or less than $0.01 per basic share, compared to a net loss of $2.0 million, or $0.06 per basic share, in the same period last year.
The vision of an "AIDS-free generation" presented in a speech earlier this month by Secretary of State Hillary Rodham Clinton "is under threat in Congress," as "the House and the Senate are discussing significant cuts to the 2012 Obama administration request for global health funding," Jeanie Yoon, a physician with Doctors Without Borders/Medecins Sans Frontieres (MSF), writes in a Baltimore Sun opinion piece.
QR Pharma, Inc., a developer of novel drugs to treat Alzheimer's disease (AD), is presenting a poster today on positive clinical data from its recent mechanism of action study in mild cognitive impaired (MCI) patients at the International Congress on Alzheimer's Disease (ICAD 2010).
› Verified 2 days ago